Search Results - "López Álvarez, M. P."

Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma by Feliu, J., López Álvarez, M. P., Jaraiz, M. A., Constenla, M., Vicent, J. M., Belón, J., López Gómez, L., de Castro, J., Dorta, J., González Barón, M.

“…BACKGROUND Use of chemotherapy for advanced pancreatic carcinoma (APC) pursues a palliative objective. Gemcitabine is active against this tumor and shows in…”
Get full text

Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group by Feliu, J, López Alvarez, M P, Jaraiz, M A, Constenla, M, Vicent, J M, Belón, J, López Gómez, L, de Castro, J, Dorta, J, González Barón, M

“…Use of chemotherapy for advanced pancreatic carcinoma (APC) pursues a palliative objective. Gemcitabine is active against this tumor and shows in vitro…”
Get full text